)
Edge23 Jan 2026
Death, Taxes, and Garbage: The Story of WM
How Waste Management turned garbage into one of America's most stable business models through landfills, regulation, and nationwide scale.
Botanix Pharmaceuticals
Botanix Pharmaceuticals (BOT) investor relations material
Botanix Pharmaceuticals Q2 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 TU earnings summary26 Jan, 2026
Executive summary
Achieved strong revenue growth and transitioned to a revenue-generating company, with cumulative gross sales reaching $93.5 million and net revenue at $21.2 million in 11 months since Sofdra's launch.
Sofdra, the first FDA-approved new chemical entity for primary axillary hyperhidrosis, saw rapid adoption with 62,500 prescriptions filled and refill rates 2.5 times the industry standard.
Sales force expanded from 27 to 50 professionals, driving increased market penetration and leveraging an innovative fulfillment platform.
Market research indicates 90% of surveyed healthcare professionals expect to increase Sofdra prescribing in the next six months.
Patent protection for Sofdra extends to 2040, supporting long-term growth.
Financial highlights
Net revenue rose 28% quarter-over-quarter to $9.1 million in Q2 FY26, up from $7.1 million in Q1 FY26.
Gross-to-net yield improved to 24% in Q2 FY26 from 23% in Q1, with a target of 30%-40% over time.
Operating cash outflow increased to $17.2 million in Q2 FY26, reflecting sales force expansion and one-time costs.
Inventory at $27.5 million supports anticipated higher prescription volumes.
Available funding totals $46.4 million, including $31.5 million in cash and $14.9 million in undrawn debt.
Outlook and guidance
Expect continued strong revenue and prescription growth, supported by expanded sales force and fulfillment platform.
Focused on achieving break-even and optimizing gross-to-net yield.
Manufacturing costs projected to remain stable, with future efficiencies anticipated from additional API suppliers aiming for 25%-40% COGS reduction.
Inventory and API purchases planned to meet rising demand.
COGS reduction timeline from new API suppliers?
Path to profitability given current cash burn?
Remuneration report shareholder engagement outcome?
What is the timeline for new API supplier COGS savings?
Assess new sales reps' Q2 performance vs. original.
What funding options for future inventory needs?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Botanix Pharmaceuticals earnings date
Q3 202622 Apr, 2026
Botanix Pharmaceuticals
Next Botanix Pharmaceuticals earnings date
Q3 202622 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Botanix Pharmaceuticals Limited is a clinical-stage pharmaceutical company focused on developing treatments for dermatological and antimicrobial conditions. The company's pipeline leverages synthetic cannabidiol (CBD) to address skin diseases such as acne, rosacea, and atopic dermatitis, as well as infections caused by antimicrobial-resistant bacteria. Botanix’s products aim to offer innovative therapies that address unmet medical needs, especially in dermatology, by combining novel formulations with delivery systems that enhance drug efficacy. The company is headquartered in North Perth, Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage